Hinge Health (NYSE:HNGE) Now Covered by Stifel Nicolaus

Stifel Nicolaus started coverage on shares of Hinge Health (NYSE:HNGE) in a research note issued to investors on Monday morning, MarketBeat Ratings reports. The firm issued a buy rating and a $48.00 price target on the stock.

A number of other equities research analysts also recently issued reports on HNGE. Royal Bank of Canada started coverage on shares of Hinge Health in a research report on Monday. They issued an “outperform” rating and a $45.00 target price for the company. Evercore ISI began coverage on shares of Hinge Health in a research note on Monday. They issued an “outperform” rating and a $50.00 target price on the stock. KeyCorp began coverage on shares of Hinge Health in a research note on Monday. They issued an “overweight” rating and a $45.00 target price on the stock. Wall Street Zen upgraded shares of Hinge Health to a “hold” rating in a research note on Monday, June 2nd. Finally, Raymond James began coverage on shares of Hinge Health in a research note on Monday. They issued an “outperform” rating and a $45.00 target price on the stock. One equities research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $46.00.

Hinge Health Price Performance

HNGE stock opened at $36.65 on Monday. Hinge Health has a 12-month low of $33.42 and a 12-month high of $43.80.

Hinge Health Company Profile

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.